Surgery

US kidney transplant survival rates continue to improve

Long-term survival rates of kidney transplant patients in the U.S. have increased over the last three decades, but there are opportunities to further improve these outcomes, according to a review article published today in ...

Overweight & Obesity

Diabetes drug's new weight loss formula fuels cost-benefit debate

The long list of side effects that follow ads for the newer expensive drugs to treat Type 2 diabetes sometimes include an unusual warning: They might cause weight loss. That side effect is one that many people—especially ...

Alzheimer's disease & dementia

Alzheimer's and aducanumab: Unjust profits and false hopes

The U.S. Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's disease raises at least three major ethical issues that need to be addressed, states a new article in the ...

Neuroscience

Cost-effectiveness of treatments in neurological diseases

Professor Dyfrig Hughes and colleagues at the Center for Health Economics and Medicines Evaluation, School of Health Sciences, have recently published the results of three clinical trials of interventions in epilepsy and ...

page 6 from 22